What Ducommun’s Latest Earnings Mean For Investors

Ducommun (DCO) reported second quarter 2026 results that came in above analyst expectations, with management pointing to missile program demand, higher engineered product content, and commercial aerospace recovery as key drivers.

Sales for the quarter were US$224.49 million compared with US$200.80 million a year earlier. Net income was US$20.40 million versus US$12.75 million, with diluted earnings per share from continuing operations at US$1.31 compared with US$0.84.

Ducommun’s recent earnings beat has arrived alongside strong price momentum, with a 30 day share price return of 19.52% and a year to date share price return of 103.78% supporting a 1 year total shareholder return of 113.16% and very large 3 year and 5 year total shareholder returns. This suggests enthusiasm has been building rather than fading.

If Ducommun’s move has you thinking about where else capital is flowing in advanced hardware and defense linked technologies, it could be a good time to scan the 39 robotics and automation stocks.

After Ducommun’s sharp re rating and with the stock almost aligned to analyst targets yet still screening at a discount to estimated intrinsic value, is the market’s caution around this move sensible or too conservative?

Most Popular Narrative: 3.4% Overvalued

The most followed narrative for Ducommun puts fair value at $190.80, slightly below the last close at $197.26. This sets up a tight valuation debate.

Ongoing mix shift toward higher-margin engineered products and aftermarket (maintained at 23% of revenues, moving toward 25%+), together with value-driven pricing and restructuring actions, is increasing gross margins (recorded at 26.6% in Q2), which supports sustained improvements in net margins and earnings.

Want to see what is sitting behind that margin story for Ducommun? The narrative leans heavily on future revenue, rising profitability, and a richer earnings multiple. The key drivers are specific and quantified. The surprise is how those pieces are stitched together into one fair value number.

Result: Fair Value of $190.80 (OVERVALUED)

However, Ducommun’s story could be knocked off course if commercial aerospace destocking drags on longer than analysts expect or if defense budget choices squeeze key missile and radar programs.

Another View On Ducommun’s Valuation

The SWS DCF model points to a fair value of $221.74 for Ducommun, compared with the current price of $197.26. That implies the stock trades about 11% below this cash flow based estimate, in contrast to the analyst narrative that frames it as 3.4% overvalued. Which lens do you find more convincing?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Ducommun for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 49 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mixed signals around Ducommun, it makes sense to look at the numbers and sentiment yourself and decide how comfortable you feel with the balance of opportunity and risk. You can start by weighing up the 2 key rewards and 1 important warning sign

Looking For More Ideas Beyond Ducommun?

If Ducommun has sharpened your focus, do not stop here. Broader context from other stocks can help you judge whether today’s opportunity set really suits your goals.

• Target resilient income by scanning companies that have been grouped as potential 8 dividend fortresses.
• Spot compelling price tags and filter for companies that appear attractively priced using the 49 high quality undervalued stocks.
• Hunt for tomorrow’s potential standouts before they hit the headlines with the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.